Clinical Trial Update: Dose Escalation Study in Acute Myeloid or B-Cell Acute Lymphoblastic Leukemia [Phase 1]

View source ↗

Summary

A Phase 1 dose-escalation study in relapsed or refractory acute myeloid leukemia and relapsed/refractory B-cell acute lymphoblastic leukemia sponsored by Verast…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Myeloid Leukemia
• B-cell Acute Lymphoblastic Leukemia

Snippet

Sponsor: Verastem, Inc. | Conditions: Relapsed or Refractory Acute Myeloid Leukemia, Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia | Phase 1 | Status: WITHDRAWN